-transparent.png){kind=logo}
Patients affected by Glanzmann's thrombasthenia often require blood and platelet transfusions due to bleeding. They may develop antibodies against platelet antigens and become refractory to platelet transfusions. In this study we present our approach to platelet transfusion in a thrombasthenic patient with platelet antibodies directed against gpIIb/IIIa. We found that platelets from two HPA1b/b donors were weakly positive when matched with the patient's serum. The patient was submitted to dental surgery and platelets were transfused before and after surgery to prevent bleeding. The patient did not experience transfusion reaction and good platelet recovery was observed.
Related Publications
R Conte, and
D Cirillo, and
F Ricci, and
C Tassi, and
P L Tazzari
May 1997,
European journal of haematology,
R Conte, and
D Cirillo, and
F Ricci, and
C Tassi, and
P L Tazzari
August 2005,
European journal of obstetrics, gynecology, and reproductive biology,
R Conte, and
D Cirillo, and
F Ricci, and
C Tassi, and
P L Tazzari
September 2019,
Thrombosis research,
R Conte, and
D Cirillo, and
F Ricci, and
C Tassi, and
P L Tazzari
March 2000,
Arteriosclerosis, thrombosis, and vascular biology,
R Conte, and
D Cirillo, and
F Ricci, and
C Tassi, and
P L Tazzari
January 1997,
Platelets,
R Conte, and
D Cirillo, and
F Ricci, and
C Tassi, and
P L Tazzari
January 1994,
Clinical and experimental rheumatology,
R Conte, and
D Cirillo, and
F Ricci, and
C Tassi, and
P L Tazzari
August 1986,
Blood,
R Conte, and
D Cirillo, and
F Ricci, and
C Tassi, and
P L Tazzari
November 1992,
Thrombosis and haemostasis,
R Conte, and
D Cirillo, and
F Ricci, and
C Tassi, and
P L Tazzari
September 1998,
British journal of haematology,
R Conte, and
D Cirillo, and
F Ricci, and
C Tassi, and
P L Tazzari
December 2017,
Archivum immunologiae et therapiae experimentalis,
